IP Library Granted Patent US 8,206,903
Granted Patent B2
US 8,206,903 · App. 11/286,882 · Granted Jun 26, 2012

Device and method for electroporation-based delivery of molecules into cells and dynamic monitoring of cell responses

Assignee: Acea Biosciences
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,206,903
App. No.
11/286,882
Granted
Jun 26, 2012
Kind
B2
Abstract

The present invention includes devices and methods for transfecting a cell or cell population and dynamic monitoring of cellular events. A variety of microelectronic devices are provide that incorporate functions such as electroporation, modulation of a transmembrane potential and dynamic monitoring of cellular functions and mechanisms.

Claims (44)

1. A method of monitoring a cellular response in real time, comprising:

a. monitoring at least one impedance measurement prior to transfecting a cell or cell population;

b. determining said cell or cell population is to be transfected if said at least one impedance measurement prior to transfecting said cell or cell population is within a predetermined range;

c. transfecting said cell or cell population with a molecule if determined to be transfected, wherein said cell or cell population is transfected using a method selected from the group consisting of a chemical transfection method, electroporation and a viral transfection method, further wherein said molecule is capable of affecting a cellular function selected from the group consisting of cell proliferation, cell adhesion and cell spreading; and

d. monitoring impedance of said cell or said cell population when said cell or said cell population is attached to an impedance-monitoring electrode.

2. The method according to claim 1 , wherein said cell is a eukaryotic cell.

3. The method according to claim 1 , wherein said cell is a mammalian cell.

4. The method according to claim 1 , wherein said molecule is selected from the group consisting of a DNA molecule, an RNA molecule, an oligopeptide, a polypeptide, a protein and a compound.

5. The method according to claim 4 , wherein said DNA molecule is selected from the group consisting of a recombinant DNA molecule, a native DNA molecule, a plasmid, a cDNA, an anti-sense DNA strand and an oligonucleotide.

6. The method according to claim 4 , wherein said RNA molecule is selected from the group consisting of a siRNA molecule, a microRNA molecule, a native RNA molecule, a ribozyme RNA and an aptamer.

7. The method according to claim 1 , wherein said molecule is a capable of affecting a process selected from the group consisting of transcription, translation, RNA splicing and RNA editing.

8. The method according to claim 1 , wherein said molecule is capable of affecting cell morphology.

9. The method according to claim 1 , further comprising conducting an endpoint assay selected from the group consisting of a cell viability assay, an apoptosis assay, an enzymatic activity assay, a signal transduction analysis assay, and a reporter assay.

10. A method of monitoring a cellular response in real time, comprising:

a. monitoring at least one impedance measurement prior to transfecting a cell or cell population;

b. determining said cell or cell population is to be transfected if said at least one impedance measurement prior to transfecting said cell or cell population is within a predetermined range;

c. transfecting said cell or cell population with a molecule if determined to be transfected, wherein said cell or cell population is transfected using a method selected from the group consisting of a chemical transfection method, electroporation and a viral transfection method, further wherein said molecule is capable of affecting a cellular receptor or a signal transduction pathway activated by said receptor; and

d. monitoring impedance of said cell or said cell population when said cell or said cell population is attached to an impedance-monitoring electrode.

11. The method according to claim 10 , further comprising conducting an endpoint assay selected from the group consisting of a cell viability assay, an apoptosis assay, an enzymatic activity assay, a signal transduction analysis assay, and a reporter assay.

12. The method according to claim 10 , wherein said cell is a eukaryotic cell.

13. The method according to claim 10 , wherein said cell is a mammalian cell.

14. The method according to claim 10 , wherein said molecule is selected from the group consisting of a DNA molecule, an RNA molecule, an oligopeptide, a polypeptide, a protein and a compound.

15. The method according to claim 14 , wherein said DNA molecule is selected from the group consisting of a recombinant DNA molecule, a native DNA molecule, a plasmid, a cDNA, an anti-sense DNA strand and an oligonucleotide.

16. The method according to claim 14 , wherein said RNA molecule is selected from the group consisting of a siRNA molecule, a microRNA molecule, a native RNA molecule, a ribozyme RNA and an aptamer.

17. The method according to claim 10 , wherein said molecule is a capable of affecting a process selected from the group consisting of transcription, translation, RNA splicing and RNA editing.

18. The method according to claim 10 , wherein said molecule is capable of affecting cell morphology.

19. A method of monitoring a cellular response in real time, comprising:

a. transfecting a cell or cell population with a molecule using electroporation, wherein said molecule is capable of affecting a cellular function selected from the group consisting of cell proliferation, cell adhesion, and cell spreading; and

b. monitoring impedance of said cell or said cell population when said cell or said cell population is attached to an impedance-monitoring electrode.

20. The method according to claim 19 , wherein said cell is a mammalian cell.

21. The method according to claim 19 , wherein said molecule is selected from the group consisting of a DNA molecule, a RNA molecule and a polypeptide.

22. The method according to claim 21 , wherein said DNA molecule is selected from the group consisting of a recombinant DNA molecule, a native DNA molecule, a plasmid, a cDNA, an anti-sense DNA strand and an oligonucleotide; and wherein said RNA molecule is selected from the group consisting of a siRNA molecule, a microRNA molecule, a native RNA molecule, a ribozyme RNA and an aptamer.

23. A method of monitoring a cellular response in real time, comprising:

a. transfecting a cell or cell population with a molecule using electroporation, wherein said molecule is capable of affecting cell morphology; and

b. monitoring impedance of said cell or said cell population when said cell or said cell population is attached to an impedance-monitoring electrode.

24. The method according to claim 23 , wherein said cell is a mammalian cell.

25. The method according to claim 23 , wherein said molecule is selected from the group consisting of a DNA molecule, a RNA molecule and a polypeptide.

26. The method according to claim 25 , wherein said DNA molecule is selected from the group consisting of a recombinant DNA molecule, a native DNA molecule, a plasmid, a cDNA, an anti-sense DNA strand and an oligonucleotide; and wherein said RNA molecule is selected from the group consisting of a siRNA molecule, a microRNA molecule, a native RNA molecule, a ribozyme RNA and an aptamer.

27. A method of monitoring a cellular response in real time, comprising:

a. transfecting a cell or cell population with a molecule using electroporation, wherein said molecule is capable of affecting a cellular receptor or a signal transduction pathway activated by said receptor; and

b. monitoring impedance of said cell or said cell population when said cell or said cell population is attached to an impedance-monitoring electrode.

28. The method according to claim 27 , wherein said cell is a mammalian cell.

29. The method according to claim 27 , wherein said molecule is selected from the group consisting of a DNA molecule, a RNA molecule and a polypeptide.

30. The method according to claim 29 , wherein said DNA molecule is selected from the group consisting of a recombinant DNA molecule, a native DNA molecule, a plasmid, a cDNA, an anti-sense DNA strand and an oligonucleotide; and wherein said RNA molecule is selected from the group consisting of a siRNA molecule, a microRNA molecule, a native RNA molecule, a ribozyme RNA and an aptamer.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2021
From: ACEA BIOSCIENCES, INC.
To: AGILENT TECHNOLOGIES, INC.
Reel/Frame 055409/0874 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2006
From: ABASSI, YAMA A.; WANG, XIAOBO; ATIENZA, JOSEPHINE; XU, XIAO; XU, JUNQUAN
To: ACEA BIOSCIENCES CORPORATION
Reel/Frame 017566/0410 →
Continuity (42)
Continuation In Part PCTUS2005034561 · Sep 27, 2005
Continuation In Part 11235938 · Sep 27, 2005
Continuation In Part 11197994 · Aug 4, 2005
Continuation In Part 11055639 · Feb 9, 2005
Continuation In Part 10987732 · Nov 12, 2004
Continuation In Part 10705447 · Nov 10, 2003
Continuation In Part 11198831 · Aug 4, 2005
Continuation In Part 10705615 · Nov 10, 2003
Provisional Application 60542927 · Feb 9, 2004
Provisional Application 60647159 · Jan 26, 2005
Provisional Application 60469572 · May 9, 2003
Provisional Application 60435400 · Dec 20, 2002
Provisional Application 60633019 · Dec 3, 2004
Provisional Application 60397749 · Jul 20, 2002
Provisional Application 60519567 · Nov 12, 2003
Provisional Application 60397749 · Jul 20, 2002
Provisional Application 60469572 · May 9, 2003
Provisional Application 60613749 · Sep 27, 2004
Provisional Application 60630809 · Nov 24, 2004
Provisional Application 60613872 · Sep 27, 2004
Provisional Application 60653904 · Feb 17, 2005
Provisional Application 60630071 · Nov 22, 2004
Provisional Application 60630131 · Nov 22, 2004
Provisional Application 60689422 · Jun 10, 2005
Provisional Application 60435400 · Dec 20, 2002
Provisional Application 60673678 · Apr 25, 2005
Provisional Application 60548713 · Feb 27, 2004
Provisional Application 60614601 · Sep 29, 2004
Provisional Application 60598608 · Aug 4, 2004
Provisional Application 60630131 · Nov 22, 2004
Provisional Application 60689422 · Jun 10, 2005
Provisional Application 60598609 · Aug 4, 2004
Provisional Application 60613749 · Sep 27, 2004
Provisional Application 60647189 · Jan 26, 2005
Provisional Application 60647075 · Jan 26, 2005
Provisional Application 60660829 · Mar 10, 2005
Provisional Application 60660898 · Mar 10, 2005
Provisional Application 60630809 · Nov 24, 2004
Provisional Application 60633019 · Dec 3, 2004
Provisional Application 60653904 · Feb 17, 2005
Provisional Application 60673678 · Apr 21, 2005
Related Publication 20060121446A1 · Jun 8, 2006